tofacitinib
In UC, Tofacitinib and Ustekinumab Perform Similarly After Biologic Failure
In biologic-experienced patients with ulcerative colitis, tofacitinib and ustekinumab achieve about the same rate ...
MAY 17, 2023
Real-World Data Help Optimize Tofacitinib Maintenance in Ulcerative Colitis
Dose de-escalation of tofacitinib appears to be safe and effective for patients with ulcerative colitis, but ...
JANUARY 25, 2023
FDA Warns of Serious Risks, Including Death, With Tofacitinib
The FDA is requiring the addition of warnings about increased risks for cancer, serious cardiovascular events and ...
SEPTEMBER 3, 2021
AGA Issues Treatment Recommendations For Moderate to Severe UC
New guidelines from the American Gastroenterological Association call for the use of biologics or the ...
NOVEMBER 14, 2019
Higher Dose of Xeljanz Increased Clot Risk in RA Study
The FDA alerted health professionals and the public about an increased risk for pulmonary embolism and death when a ...
FEBRUARY 27, 2019
